Listed

Clover Health Investments, Corp.

CLOVNasdaqCIK 1801170FinancialsFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last eight fiscal years. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.92bn, FY2025
Operating income−$85.5m, FY2025
Net income−$85.5m, FY2025
Clover Health Investments, Corp., income statement, annual
Line itemUnitFY2019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Revenue$m462Revenue, period not labelled, twelve months to 2019-12-31$462.3m. XBRL concept us-gaap:Revenues. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure673Revenue, FY2020, twelve months to 2020-12-31$672.9m. XBRL concept us-gaap:Revenues. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure1,472Revenue, FY2021, twelve months to 2021-12-31$1.47bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure1,097Revenue, FY2022, twelve months to 2022-12-31$1.10bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure1,261Revenue, FY2023, twelve months to 2023-12-31$1.26bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure1,371Revenue, FY2024, twelve months to 2024-12-31$1.37bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure1,924Revenue, FY2025, twelve months to 2025-12-31$1.92bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure
Gross profit$mnot reportednot reported(79.2)Gross profit, FY2021, twelve months to 2021-12-31−$79.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure70.2Gross profit, FY2022, twelve months to 2022-12-31$70.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure257Gross profit, FY2023, twelve months to 2023-12-31$257.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figurenot reportednot reported
Operating income$m(183)Operating income, period not labelled, twelve months to 2019-12-31−$183.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure(92.7)Operating income, FY2020, twelve months to 2020-12-31−$92.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure(637)Operating income, FY2021, twelve months to 2021-12-31−$637.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure(287)Operating income, FY2022, twelve months to 2022-12-31−$286.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure(205)Operating income, FY2023, twelve months to 2023-12-31−$205.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure(45.7)Operating income, FY2024, twelve months to 2024-12-31−$45.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure(85.5)Operating income, FY2025, twelve months to 2025-12-31−$85.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure
Interest expense$m23.2Interest expense, period not labelled, twelve months to 2019-12-31$23.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure36.0Interest expense, FY2020, twelve months to 2020-12-31$36.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure3.2Interest expense, FY2021, twelve months to 2021-12-31$3.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure1.3Interest expense, FY2022, twelve months to 2022-12-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure0.0Interest expense, FY2023, twelve months to 2023-12-31$7.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure0.0Interest expense, FY2024, twelve months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure0.0Interest expense, FY2025, twelve months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure
Income tax$m0.0Income tax, period not labelled, twelve months to 2019-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure0.0Income tax, FY2020, twelve months to 2020-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure0.0Income tax, FY2021, twelve months to 2021-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure0.0Income tax, FY2022, twelve months to 2022-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure0.0Income tax, FY2023, twelve months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure0.0Income tax, FY2024, twelve months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure0.0Income tax, FY2025, twelve months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure
Net income$m(364)Net income, period not labelled, twelve months to 2019-12-31−$363.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure(136)Net income, FY2020, twelve months to 2020-12-31−$136.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure(588)Net income, FY2021, twelve months to 2021-12-31−$587.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure(340)Net income, FY2022, twelve months to 2022-12-31−$339.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure(213)Net income, FY2023, twelve months to 2023-12-31−$213.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure(43.0)Net income, FY2024, twelve months to 2024-12-31−$43.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure(85.5)Net income, FY2025, twelve months to 2025-12-31−$85.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure
Diluted EPS$ per share(4.14)Diluted EPS, period not labelled, twelve months to 2019-12-31−$4.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure(1.54)Diluted EPS, FY2020, twelve months to 2020-12-31−$1.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure(1.42)Diluted EPS, FY2021, twelve months to 2021-12-31−$1.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure(0.71)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure(0.44)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figurenot reportednot reported
Basic EPS$ per share(4.14)Basic EPS, period not labelled, twelve months to 2019-12-31−$4.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure(1.54)Basic EPS, FY2020, twelve months to 2020-12-31−$1.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure(1.42)Basic EPS, FY2021, twelve months to 2021-12-31−$1.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure(0.71)Basic EPS, FY2022, twelve months to 2022-12-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure(0.44)Basic EPS, FY2023, twelve months to 2023-12-31−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figurenot reportednot reported

Balance sheet

Cash and equivalents$78.3m, FY2025
Long-term debt$0, FY2022
Shareholders' equity$308.7m, FY2025
Clover Health Investments, Corp., balance sheet, annual
Line itemUnitFY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$m92.3Cash and equivalents, FY2020, at 2020-12-31$92.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure300Cash and equivalents, FY2021, at 2021-12-31$300.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure104Cash and equivalents, FY2022, at 2022-12-31$103.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure123Cash and equivalents, FY2023, at 2023-12-31$122.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure195Cash and equivalents, FY2024, at 2024-12-31$194.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure78.3Cash and equivalents, FY2025, at 2025-12-31$78.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure
Current assets$m190Current assets, FY2020, at 2020-12-31$189.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure753Current assets, FY2021, at 2021-12-31$752.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure625Current assets, FY2022, at 2022-12-31$625.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure428Current assets, FY2023, at 2023-12-31$428.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure343Current assets, FY2024, at 2024-12-31$343.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure308Current assets, FY2025, at 2025-12-31$307.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Total assets$m267Total assets, FY2020, at 2020-12-31$267.3m. XBRL concept us-gaap:Assets. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure951Total assets, FY2021, at 2021-12-31$950.8m. XBRL concept us-gaap:Assets. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure809Total assets, FY2022, at 2022-12-31$808.6m. XBRL concept us-gaap:Assets. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure571Total assets, FY2023, at 2023-12-31$570.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure581Total assets, FY2024, at 2024-12-31$580.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure541Total assets, FY2025, at 2025-12-31$541.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Current liabilities$m164Current liabilities, FY2020, at 2020-12-31$164.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure372Current liabilities, FY2021, at 2021-12-31$371.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure432Current liabilities, FY2022, at 2022-12-31$431.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure261Current liabilities, FY2023, at 2023-12-31$261.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure214Current liabilities, FY2024, at 2024-12-31$213.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure209Current liabilities, FY2025, at 2025-12-31$208.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Total liabilities$m433Total liabilities, FY2020, at 2020-12-31$432.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure411Total liabilities, FY2021, at 2021-12-31$410.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure452Total liabilities, FY2022, at 2022-12-31$451.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure284Total liabilities, FY2023, at 2023-12-31$284.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure240Total liabilities, FY2024, at 2024-12-31$239.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure232Total liabilities, FY2025, at 2025-12-31$232.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Long-term debt$m106Long-term debt, FY2020, at 2020-12-31$106.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure19.9Long-term debt, FY2021, at 2021-12-31$19.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure0.0Long-term debt, FY2022, at 2022-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figurenot reportednot reportednot reported
Current portion of debt$m20.8Current portion of debt, FY2020, at 2020-12-31$20.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure0.0Current portion of debt, FY2021, at 2021-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figurenot reportednot reportednot reportednot reported
Shareholders' equity$m(617)Shareholders' equity, FY2020, at 2020-12-31−$617.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure535Shareholders' equity, FY2021, at 2021-12-31$535.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure357Shareholders' equity, FY2022, at 2022-12-31$356.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-05-09, accession 0001801170-23-000038.Report this figure286Shareholders' equity, FY2023, at 2023-12-31$286.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure341Shareholders' equity, FY2024, at 2024-12-31$341.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure309Shareholders' equity, FY2025, at 2025-12-31$308.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure

Cash flow

Operating cash flow−$66.9m, FY2025
Capital expenditure$2.0m, FY2025
Share repurchases$18.3m, FY2025
Clover Health Investments, Corp., cash flow, annual
Line itemUnitFY2019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Operating cash flow$m(160)Operating cash flow, period not labelled, twelve months to 2019-12-31−$159.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure(118)Operating cash flow, FY2020, twelve months to 2020-12-31−$118.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure(282)Operating cash flow, FY2021, twelve months to 2021-12-31−$282.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure(204)Operating cash flow, FY2022, twelve months to 2022-12-31−$203.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure(145)Operating cash flow, FY2023, twelve months to 2023-12-31−$144.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure34.8Operating cash flow, FY2024, twelve months to 2024-12-31$34.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure(66.9)Operating cash flow, FY2025, twelve months to 2025-12-31−$66.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure
Capital expenditure$m0.0Capital expenditure, period not labelled, twelve months to 2019-12-31$23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure0.7Capital expenditure, FY2020, twelve months to 2020-12-31$693.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure0.7Capital expenditure, FY2021, twelve months to 2021-12-31$723.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure4.5Capital expenditure, FY2022, twelve months to 2022-12-31$4.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure0.6Capital expenditure, FY2023, twelve months to 2023-12-31$584.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure1.6Capital expenditure, FY2024, twelve months to 2024-12-31$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure2.0Capital expenditure, FY2025, twelve months to 2025-12-31$2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure
Share repurchases$m0.0Share repurchases, period not labelled, twelve months to 2019-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure0.0Share repurchases, FY2020, twelve months to 2020-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure0.1Share repurchases, FY2021, twelve months to 2021-12-31$147.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure0.0Share repurchases, FY2022, twelve months to 2022-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure0.0Share repurchases, FY2023, twelve months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure1.8Share repurchases, FY2024, twelve months to 2024-12-31$1.8m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure18.3Share repurchases, FY2025, twelve months to 2025-12-31$18.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure

Shares

Diluted shares (weighted)511.97m, FY2025
Clover Health Investments, Corp., shares, annual
Line itemUnitFY2019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Diluted shares (weighted)m shares87.8Diluted shares (weighted), period not labelled, twelve months to 2019-12-3187,829,419 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2022-02-28, accession 0001801170-22-000015.Report this figure88.7Diluted shares (weighted), FY2020, twelve months to 2020-12-3188,691,582 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2023-03-01, accession 0001801170-23-000015.Report this figure413Diluted shares (weighted), FY2021, twelve months to 2021-12-31412,922,424 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2024-03-14, accession 0001801170-24-000064.Report this figure476Diluted shares (weighted), FY2022, twelve months to 2022-12-31476,244,262 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure482Diluted shares (weighted), FY2023, twelve months to 2023-12-31482,176,127 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure490Diluted shares (weighted), FY2024, twelve months to 2024-12-31490,018,730 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure512Diluted shares (weighted), FY2025, twelve months to 2025-12-31511,967,146 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.